Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury
Open accessAbstract
The binding of advanced glycation end-products (AGE) to the receptor for AGE (RAGE) is known to deteriorate various cell functions and is implicated in the pathogenesis of diabetic vascular complications. In the present study, we show that the cellular constituents of small vessels, endothelial cells (EC) and pericytes express novel splice variants of RAGE mRNA coding for the isoforms that lack the N-terminal V-type immunoglobulin-like domain (N-truncated) or the C-terminal transmembrane domain (C-truncated), as well as the known full-length mRNA. The ratio of the expression of the three variants was different between EC and pericytes; the content of the C-truncated form was highest in EC, whereas the full-length form was the most abundant in pericytes. Transfection experiments with COS-7 cells demonstrated that those variant mRNAs were translated into proteins as deduced; C-truncated RAGE was efficiently secreted into the culture media, and N-truncated RAGE was located mainly on the plasma membrane. The three isoforms were also detected in primary cultured human EC and pericytes. Further, full-length and C-truncated forms of RAGE bound to an AGE-conjugated column, whereas N-truncated RAGE did not. The AGE induction of extracellular-signal-related kinase phosphorylation and vascular endothelial growth factor in EC and of the growth and cord-like structure formation of EC was abolished completely by C-truncated RAGE, indicating that this endogenous secretory receptor (endogenous secretory RAGE) is cytoprotective against AGE. The results may contribute to our understanding of the molecular basis for the diversity of cellular responses to AGE and for individual variations in the susceptibility to diabetic vascular complications.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
RAGE is not known to be related to oxytocin or oxytocin signalling.
“RAGE, a member of the immunoglobulin superfamily of pattern recognition receptors, is not known to be related to oxytocin or oxytocin signalling22–33.”
From Vascular RAGE transports oxytocin into the brain to elicit its maternal bonding behaviour in mice (2019) · cites this paper as [29]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302 · see citing works
Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104 · see citing works
Lang, G. E., Vaiser, A., Snyder, W. B., & Lynn, J. R. (1974) · doi:10.1159/isbn.978-3-318-01439-6 · Cited by 5,583 · see citing works
Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic Complications
Flier, J. S., Underhill, L. H., Brownlee, M., Cerami, A., & Vlassara, H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805193182007 · Cited by 2,512 · see citing works
RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., et al. (1996) · Nature · doi:10.1038/382685a0 · Cited by 2,012 · see citing works
RAGE Mediates a Novel Proinflammatory Axis
Hofmann, M. A., Drury, S., Fu, C., Qu, W., Taguchi, A., Lu, Y., Avila, C., Kambham, N., Bierhaus, A., Nawroth, P., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80801-6 · Cited by 1,864 · see citing works
Neeper, M. P., Schmidt, A. M., Brett, J., Yan, S. D., Wang, F., Pan, Y., Elliston, K. O., Stern, D., & SHAW, A. R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42138-2 · Cited by 1,542 · see citing works
Yan, S. D., Schmidt, A. M., Anderson, G. M., Zhang, J., Brett, J., Zou, Y., Pinsky, D. J., & Stern, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36966-1 · Cited by 1,305 · see citing works
The Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin
Hori, O., Brett, J., Slattery, T., Cao, R., Zhang, J., Chen, J. X., Nagashima, M., Lundh, E. R., Vijay, S., Nitecki, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25752 · Cited by 1,151 · see citing works
Deglycosylation of asparagine-linked glycans by peptide:N-glycosidase F
Tarentino, A. L., Gomez, C. M., & Plummer, T. H. (1985) · Biochemistry · doi:10.1021/bi00338a028 · Cited by 1,130 · see citing works
Park, L., Raman, K. G., Lee, K. J., Lu, Y., Ferran, L. J., Chow, W. S., Stern, D. M., & Schmidt, A. M. (1998) · Nature Medicine · doi:10.1038/2012 · Cited by 1,103 · see citing works
Tusnády, G., & Simon, I. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2107 · Cited by 1,073 · see citing works
Schmidt, A. M., Hori, O., Chen, J. X., Li, J. F., Crandall, J., Zhang, J., Cao, R., Yan, S. D., Brett, J., & Stern, D. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118175 · Cited by 896 · see citing works
Kislinger, T., Fu, C., Huber, B., Qu, W., Taguchi, A., Yan, S. D., Hofmann, M. A., Yan, S. F., Pischetsrieder, M., Stern, D. M., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.44.31740 · Cited by 868 · see citing works
Schmidt, A. M., Vianna, M., Gerlach, M. L., Brett, J., Ryan, J., Kao, J. J., Esposito, C., Hegarty, H. M., Hurley, W. L., & Clauss, M. A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42137-0 · Cited by 833 · see citing works
Lander, H. M., Tauras, J. M., Ogiste, J. S., Hori, O., Moss, R. A., & Schmidt, A. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.28.17810 · Cited by 813 · see citing works
Cogan, D. G. (1961) · Archives of Ophthalmology · doi:10.1001/archopht.1961.00960010368014 · Cited by 807 · see citing works
Brett, J., Schmidt, A. M., Yan, S. D., Zou, Y. S., Weidman, E., Pinsky, D. J., Nowygrod, R., Neeper, M. P., Przysiecki, C. T., & SHAW, A. R. (1993) · PubMed Central · Cited by 776 · see citing works
Huttunen, H. J., Fages, C., & Rauvala, H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19919 · Cited by 629 · see citing works
Wautier, J., Zoukourian, C., Chappey, O., Wautier, M.-P., Guillausseau, P.-J., Cao, R. Y., Hori, O., Stern, D., & Schmidt, A. M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118397 · Cited by 551 · see citing works
Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice
Yamamoto, Y., Kato, I., Doi, T., Yonekura, H., Ohashi, S., Takeuchi, M., Watanabe, T., Yamagishi, S.-I., Sakurai, S., Takasawa, S., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11771 · Cited by 475 · see citing works
Self-citationTanaka, N., Yonekura, H., Yamagishi, S., Fujimori, H., Yamamoto, Y., & Yamamoto, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001235200 · Cited by 425 · see citing works
Self-citationSpontaneous transformation and immortalization of human endothelial cells
Takahashi, K., Sawasaki, Y., Hata, J., Mukai, K., & Goto, T. (1990) · In Vitro Cellular & Developmental Biology - Plant · doi:10.1007/bf02624456 · Cited by 419 · see citing works
Thornalley, P. J. (1998) · PubMed · Cited by 387 · see citing works
Schmidt, A. M., Hasu, M., Popov, D., Zhang, J. H., Chen, J., Yan, S. D., Brett, J., Cao, R. Y., Kuwabara, K., & Costache, G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.8807 · Cited by 327 · see citing works
Nomura, M., Yamagishi, S., Harada, S.-I., Hayashi, Y., Yamashima, T., Yamashita, J., & Yamamoto, H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.47.28316 · Cited by 297 · see citing works
Self-citationAdvanced Glycation End Products-driven Angiogenesis in Vitro
Yamagishi, S., Yonekura, H., Yamamoto, Y., Katsuno, K., Sato, F., Mita, I., O'OKA, H., Satozawa, N., Kawakami, T., Nomura, M., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.13.8723 · Cited by 274 · see citing works
Self-citationSugaya, K., Fukagawa, T., Matsumoto, K., Mita, K., Takahashi, E., Ando, A., Inoko, H., & Ikemura, T. (1994) · Genomics · doi:10.1006/geno.1994.1517 · Cited by 242 · see citing works
Significance of Ventricular Myocytes and Nonmyocytes Interaction During Cardiocyte Hypertrophy
Harada, M., Itoh, H., Nakagawa, O., Ogawa, Y., Miyamoto, Y., Kuwahara, K., Ogawa, E., Igaki, T., Yamashita, J. K., Masuda, I., et al. (1997) · Circulation · doi:10.1161/01.cir.96.10.3737 · Cited by 235 · see citing works
Yamagishi, S., Fujimori, H., Yonekura, H., Yamamoto, Y., & Yamamoto, H. (1998) · Diabetologia · doi:10.1007/s001250051089 · Cited by 193 · see citing works
Self-citationTakeuchi, M., Makita, Z., Bucala, R., Suzuki, T., Koike, T., & Kameda, Y. (2000) · Molecular Medicine · doi:10.1007/bf03401779 · Cited by 192 · see citing works
Self-citationYonekura, H., Sakurai, S., Liu, X., Migita, H., Wang, H., Yamagishi, S., Nomura, M., Abedin, M. J., Unoki‐Kubota, H., Yamamoto, Y., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.49.35172 · Cited by 192 · see citing works
Self-citationRegulation of Vascular Endothelial Growth Factor Expression by Advanced Glycation End Products
Treins, C., Giorgetti-Peraldi, S., Murdaca, J., & Van Obberghen, E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106534200 · Cited by 191 · see citing works
Schmidt, A., & Stern, D. (2000) · Trends in endocrinology and metabolism · doi:10.1016/s1043-2760(00)00311-8 · Cited by 173 · see citing works
Malherbe, P., Richards, J. G., Gaillard, H., Thompson, A., Diener, C., Schuler, A., & Huber, G. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00174-6 · Cited by 142 · see citing works
Yamagishi, S., Hsu, C., Taniguchi, M., Harada, S. I., Yamamoto, Y., Ohsawa, K. S., Kobayashi, K. I., & Yamamoto, H. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2185 · Cited by 126 · see citing works
Self-citationBag, J., & Sarkar, S. (1975) · Biochemistry · doi:10.1021/bi00688a012 · Cited by 108 · see citing works
Akaogi, K., Okabe, Y., Sato, J., Nagashima, Y., Yasumitsu, H., Sugahara, K., & Miyazaki, K. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8384 · Cited by 107 · see citing works
Takeuchi, M., & Makita, Z. (2001) · Current Molecular Medicine · doi:10.2174/1566524013363735 · Cited by 70 · see citing works
Self-citationRoles of the AGE‐RAGE System in Vascular Injury in Diabetesa
Yamamoto, Y., Yamagishi, S., Yonekura, H., Doi, T., Tsuji, H., KATO, I., Takasawa, S., OKAMOTO, H., Abedin, J., Tanaka, N., et al. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06311.x · Cited by 69 · see citing works
Self-citationDevelopment and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice
Yamamoto, Y., Kato, I., Doi, T., Yonekura, H., Ohashi, S., Takeuchi, M., Watanabe, T., Yamagishi, S., Sakurai, S., Takasawa, S., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200111771 · Cited by 54 · see citing works
Self-citationRibozyme Targeting of Receptor for Advanced Glycation End Products in Mouse Mesangial Cells
Tsuji, H., Iehara, N., Masegi, T., Imura, M., Ohkawa, J., Arai, H., Ishii, K., Kita, T., & Doi, T. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8489 · Cited by 50 · see citing works
Yamagishi, S.-I., Yamamoto, Y., Harada, S.-I., Hsu, C., & Yamamoto, H. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00279-7 · Cited by 47 · see citing works
Self-citationKim, K.-Y., Jeong, S.-Y., Won, J., Ryu, P. D., & Nam, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104944200 · Cited by 36 · see citing works
Flagged first, then by citations
2 of the 46 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Mechanisms of Diabetic Complications
Forbes, J. M., & Cooper, M. E. (2013) · Physiological Reviews · doi:10.1152/physrev.00045.2011 · Cited by 2,890 · see citing works
Understanding RAGE, the receptor for advanced glycation end products
Bierhaus, A., Humpert, P. M., Morcos, M., Wendt, T., Chavakis, T., Arnold, B., Stern, D. M., & Nawroth, P. P. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0688-7 · Cited by 1,297 · see citing works
Role of advanced glycation end products in cellular signaling
Ott, C., Jacobs, K., Haucke, E., Navarrete Santos, A., Grune, T., & Simm, A. (2014) · Redox Biology · doi:10.1016/j.redox.2013.12.016 · Cited by 1,150 · see citing works
Mechanisms of diabetes mellitus-induced bone fragility
On behalf of the IOF Bone and Diabetes Working Group, Napoli, N., Chandran, M., Pierroz, D. D., Abrahamsen, B., Schwartz, A. V., & Ferrari, S. L. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.153 · Cited by 1,107 · see citing works
Sparvero, L. J., Asafu-Adjei, D. A., Kang, R., Tang, D., Amin, N., Im, J., Rutledge, R., Lin, B., Amoscato, A. A., Zeh, H. J., et al. (2009) · Journal of Translational Medicine · doi:10.1186/1479-5876-7-17 · Cited by 625 · see citing works
Raucci, A., Cugusi, S., Antonelli, A., Barabino, S. M. L., Monti, L. D., Bierhaus, A., Reiß, K., Säftig, P., & Bianchi, M. E. (2008) · The FASEB Journal · doi:10.1096/fj.08-109033 · Cited by 560 · see citing works
Abeyama, K., Stern, D. M., Ito, Y., Kawahara, K., Yoshimoto, Y., Tanaka, M., Uchimura, T., Ida, N., Yamazaki, Y., Yamada, S., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci22782 · Cited by 547 · see citing works
Self-citationAdvanced glycation endproducts and their receptor RAGE in Alzheimer's disease
Srikanth, V., Maczurek, A., Phan, T., Steele, M., Westcott, B., Juskiw, D., & Münch, G. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.04.016 · Cited by 524 · see citing works
Cellular signalling of the receptor for advanced glycation end products (RAGE)
Xie, J., Méndez, J. D., Méndez-Valenzuela, V., & Aguilar-Hernández, M. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.06.013 · Cited by 515 · see citing works
Targeting RAGE Signaling in Inflammatory Disease
Hudson, B. I., & Lippman, M. E. (2017) · Annual Review of Medicine · doi:10.1146/annurev-med-041316-085215 · Cited by 511 · see citing works
Binding of S100 proteins to RAGE: An update
Leclerc, E., Fritz, G., Vetter, S. W., & Heizmann, C. W. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.11.016 · Cited by 490 · see citing works
Papachristoforou, E., Lambadiari, V., Maratou, E., & Makrilakis, K. (2020) · Journal of Diabetes Research · doi:10.1155/2020/7489795 · Cited by 497 · see citing works
Mechanism of Development of Atherosclerosis and Cardiovascular Disease in Diabetes Mellitus
Katakami, N. (2017) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.rv17014 · Cited by 472 · see citing works
RAGE-Induced Cytosolic ROS Promote Mitochondrial Superoxide Generation in Diabetes
Coughlan, M. T., Thorburn, D. R., Penfold, S. A., Laskowski, A., Harcourt, B. E., Sourris, K. C., Tan, A. L. Y., Fukami, K., Thallas‐Bonke, V., Nawroth, P. P., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008050514 · Cited by 472 · see citing works
Receptor for Advanced Glycation End-Products is a Marker of Type I Cell Injury in Acute Lung Injury
Uchida, T., Shirasawa, M., Ware, L. B., 小島, 勝., Hata, Y., Makita, K., Mednick, G., Matthay, Z. A., & Matthay, M. A. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200509-1477oc · Cited by 468 · see citing works
Wautier, J., & Schmidt, A. M. (2004) · Circulation Research · doi:10.1161/01.res.0000137876.28454.64 · Cited by 434 · see citing works
Soro-Paavonen, A., Watson, A. M. D., Li, J., Paavonen, K., Koitka, A., Calkin, A. C., Barit, D., Coughlan, M. T., Drew, B. G., Lancaster, G. I., et al. (2008) · Diabetes · doi:10.2337/db07-1808 · Cited by 407 · see citing works
Advanced glycation end products and the kidney
Bohlender, J. M., Franke, S., Stein, G., & Wolf, G. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00398.2004 · Cited by 386 · see citing works
Falcone, C., Emanuele, E., D’Angelo, A., Buzzi, M. P., Belvito, C., Cuccia, M., & Geroldi, D. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000160342.20342.00 · Cited by 378 · see citing works
Advanced glycation endproducts: what is their relevance to diabetic complications?
Ahmed, N., & Thornalley, P. J. (2006) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00595.x · Cited by 369 · see citing works
Identification, classification, and expression of RAGE gene splice variants
Hudson, B. I., Carter, A. M., Harja, E., Kalea, A. Z., Arriero, M., Yang, H., Grant, P. J., & Schmidt, A. M. (2007) · The FASEB Journal · doi:10.1096/fj.07-9909com · Cited by 366 · see citing works
Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE–/– mice
Harja, E., Bu, D.-X., Hudson, B. I., Chang, J. S., Shen, X., Hallam, K. M., Kalea, A. Z., Lu, Y., Rosario, R., Oruganti, S., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32703 · Cited by 365 · see citing works
Basta, G. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.07.025 · Cited by 357 · see citing works
Sunahori, K., Yamamura, M., Yamana, J., Takasugi, K., Kawashima, M., Yamamoto, H., Chazin, W., Nakatani, Y., Yui, S., & Makino, H. (2006) · Arthritis Research & Therapy · doi:10.1186/ar1939 · Cited by 324 · see citing works
Self-citationKoyama, H., Shoji, T., Yokoyama, H., Motoyama, K., Mori, K., Fukumoto, S., Emoto, M., Shoji, T., Tamei, H., Matsuki, H., et al. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000190660.32863.cd · Cited by 311 · see citing works
Self-citationTargeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective
Bongarzone, S., Savickas, V., Luzi, F., & Gee, A. D. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00058 · Cited by 313 · see citing works
Ghavami, S., Rashedi, I., Dattilo, B. M., Eshraghi, M., Chazin, W., Hashemi, M. M., Wesselborg, S., Kerkhoff, C., & Łoś, M. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0607397 · Cited by 312 · see citing works
Zhang, L., Bukulin, M., Kojro, E., Roth, A., Metz, V. V., Fahrenholz, F., Nawroth, P. P., Bierhaus, A., & Postina, R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806948200 · Cited by 285 · see citing works
Proteins in Human Brain Cortex Are Modified by Oxidation, Glycoxidation, and Lipoxidation
Pamplona, R., Dalfó, E., Ayala, V., Bellmunt, M. J., Prat, J., Ferrer, I., & Portero‐Otín, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502255200 · Cited by 280 · see citing works
The Role of Advanced Glycation End Products in Diabetic Vascular Complications
Rhee, S. Y., & Kim, Y. S. (2018) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2017.0105 · Cited by 274 · see citing works
Leclerc, E., Fritz, G., Weibel, M., Heizmann, C. W., & Galichet, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703951200 · Cited by 264 · see citing works
Regulation of monocyte migration by amphoterin (HMGB1)
Rouhiainen, A. (2004) · Blood · doi:10.1182/blood-2003-10-3536 · Cited by 251 · see citing works
Demling, N., Ehrhardt, C., Kasper, M. E., Laue, M. M., Knels, L., & Rieber, E. P. (2005) · Cell and Tissue Research · doi:10.1007/s00441-005-0069-0 · Cited by 249 · see citing works
RAGE Control of Diabetic Nephropathy in a Mouse Model
Myint, K.-M., Yamamoto, Y., Doi, T., Kato, I., Harashima, A., Yonekura, H., Watanabe, T., Shinohara, H., Takeuchi, M., Tsuneyama, K., et al. (2006) · Diabetes · doi:10.2337/db06-0221 · Cited by 248 · see citing works
Self-citationThe Receptor for Advanced Glycation End Products (RAGE) and the Lung
Buckley, S. T., & Ehrhardt, C. (2010) · BioMed Research International · doi:10.1155/2010/917108 · Cited by 248 · see citing works
Advanced glycation endproducts (AGEs): pharmacological inhibition in diabetes
Peyroux, J., & Sternberg, M. (2006) · Pathologie Biologie · doi:10.1016/j.patbio.2006.07.006 · Cited by 247 · see citing works
Loeser, R. F., Yammani, R. R., Carlson, C. S., Chen, H., Cole, A. A., Im, H., Bursch, L. S., & Yan, S. D. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21199 · Cited by 244 · see citing works
HMGB1 as biomarker and drug target
Vénéreau, E., Leo, F. D., Mezzapelle, R., Careccia, G., Musco, G., & Bianchi, M. E. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.06.031 · Cited by 240 · see citing works
Receptor for Advanced Glycation End Products and Its Involvement in Inflammatory Diseases
Chuah, Y. K., Basir, R., Talib, H., Tie, T. H., & Nordin, N. (2013) · International Journal of Inflammation · doi:10.1155/2013/403460 · Cited by 243 · see citing works
Yan, S. F., Ramasamy, R., & Schmidt, A. M. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0439-2 · Cited by 236 · see citing works
Angiogenetic Signaling through Hypoxia
Schlueter, C., Weber, H., Meyer, B., Rogalla, P., Röser, K., Hauke, S., & Bullerdiek, J. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62344-9 · Cited by 229 · see citing works
Oczypok, E. A., Perkins, T. N., & Oury, T. D. (2017) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2017.03.012 · Cited by 225 · see citing works
Advanced glycation end‐products and the kidney
Busch, M., Franke, S., Rüster, C., & Wolf, G. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02317.x · Cited by 226 · see citing works
Hanford, L. E., Enghild, J. J., Valnickova, Z., Petersen, S. V., Schaefer, L. M., Schaefer, T. M., Reinhart, T. A., & Oury, T. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409782200 · Cited by 217 · see citing works
Advanced glycation end products, diabetes, and bone strength
Yamamoto, M., & Sugimoto, T. (2016) · Current Osteoporosis Reports · doi:10.1007/s11914-016-0332-1 · Cited by 215 · see citing works
Forbes, J. M., Thorpe, S. R., Thallas‐Bonke, V., Pete, J., Thomas, M. C., Deemer, E. R., Bassal, S., El‐Osta, A., Long, D. M., Panagiotopoulos, S., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010062 · Cited by 211 · see citing works
Septic Shock Is Associated with Receptor for Advanced Glycation End Products Ligation of LPS
Yamamoto, Y., Harashima, A., Saito, H., Tsuneyama, K., Munesue, S., Motoyoshi, S., Han, D., Watanabe, T., Asano, M., Takasawa, S., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002253 · Cited by 207 · see citing works
Self-citationFructose-mediated non-enzymatic glycation: sweet coupling or bad modification
Schalkwijk, C. G., Stehouwer, C. D. A., & van Hinsbergh, V. W. M. (2004) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.488 · Cited by 206 · see citing works
Basta, G., Sironi, A. M., Lazzerini, G., Turco, S. D., Buzzigoli, E., Casolaro, A., Natali, A., Ferrannini, E., & Gastaldelli, A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2559 · Cited by 204 · see citing works
Intervention against the Maillard reaction in vivo
Monnier, V. M. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.08.014 · Cited by 196 · see citing works
AGEs, RAGEs and s-RAGE; friend or foe for cancer
Ahmad, S., Khan, H., Siddiqui, Z., Khan, M. Y., Rehman, S., Shahab, U., Godovikova, T. S., Silnikov, V. N., & Moinuddin, M. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.07.001 · Cited by 196 · see citing works
RAGE biology, atherosclerosis and diabetes
Barlovič, D. P., Soro‐Paavonen, A., & Jandeleit-Dahm, K. A. M. (2011) · Clinical Science · doi:10.1042/cs20100501 · Cited by 195 · see citing works
RAGE signaling in inflammation and arterial aging
Li, L. (2009) · Frontiers in bioscience · doi:10.2741/3315 · Cited by 193 · see citing works
Dattilo, B. M., Fritz, G., Leclerc, E., Kooi, C. W. V., Heizmann, C. W., & Chazin, W. (2007) · Biochemistry · doi:10.1021/bi7003735 · Cited by 193 · see citing works
Maillard-Lefebvre, H., Boulanger, E., Daroux, M., Gaxatte, C., Hudson, B. I., & Lambert, M. (2009) · Rheumatology · doi:10.1093/rheumatology/kep199 · Cited by 190 · see citing works
Geroldi, D., Falcone, C., Emanuele, E., D’Angelo, A., Calcagnino, M. M., Buzzi, M. P., Scioli, G. A., & Fogari, R. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000177535.45785.64 · Cited by 190 · see citing works
Advanced Glycation End Products: Building on the Concept of the “Common Soil” in Metabolic Disease
Ruiz, H. H., Ramasamy, R., & Schmidt, A. M. (2019) · Endocrinology · doi:10.1210/endocr/bqz006 · Cited by 186 · see citing works
RAGE: a novel biological and genetic marker for vascular disease
Kalea, A. Z., Schmidt, A. M., & Hudson, B. I. (2009) · Clinical Science · doi:10.1042/cs20080494 · Cited by 184 · see citing works
Diabetic Nephropathy: Where Hemodynamics Meets Metabolism
Forbes, J. M., Fukami, K., & Cooper, M. E. (2007) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2007-949721 · Cited by 183 · see citing works
Vascular RAGE transports oxytocin into the brain to elicit its maternal bonding behaviour in mice
Yamamoto, Y., Liang, M., Munesue, S., Deguchi, K., Harashima, A., Furuhara, K., Yuhi, T., Zhong, J., Akther, S., Goto, H., et al. (2019) · Communications Biology · doi:10.1038/s42003-019-0325-6 · Cited by 171 · see citing works
Self-citationHMGB1, TLR and RAGE: a functional tripod that leads to diabetic inflammation
Nogueira‐Machado, J. A., Volpe, C. M. O., Veloso, C. A., & Chaves, M. M. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.575360 · Cited by 168 · see citing works
Targeting inflammation in diabetic nephropathy: a tale of hope
Moreno, J. A., Gómez‐Guerrero, C., Mas, S., Sanz, A. B., Lorenzo, Ó., Ruiz‐Ortega, M., Opazo-Ríos, L., Mezzano, S. A., & Egido, J. (2018) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2018.1538352 · Cited by 170 · see citing works
Soluble RAGE: Therapy and biomarker in unraveling the RAGE axis in chronic disease and aging
Yan, S. F., Ramasamy, R., & Schmidt, A. M. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.01.013 · Cited by 169 · see citing works
The AGE-RAGE Axis: Implications for Age-Associated Arterial Diseases
Senatus, L. M., & Schmidt, A. M. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00187 · Cited by 167 · see citing works
Pullerits, R., Bokarewa, M. I., Dahlberg, L., & Tarkowski, A. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1749 · Cited by 166 · see citing works
Ectopic fat and cardiovascular disease: What is the link?
Gastaldelli, A., & Basta, G. (2010) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.05.005 · Cited by 162 · see citing works
Advanced glycation endproducts: from precursors to RAGE: round and round we go
Ramasamy, R., Yan, S. F., & Schmidt, A. M. (2010) · Amino Acids · doi:10.1007/s00726-010-0773-2 · Cited by 158 · see citing works
Pathologies Involving the S100 Proteins and Rage
Heizmann, C. W., Ackermann, G. E., & Galichet, A. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6191-2_5 · Cited by 160 · see citing works
Morbini, P., Villa, C., Campo, I., Zorzetto, M., Inghilleri, S., & Luisetti, M. (2006) · Modern Pathology · doi:10.1038/modpathol.3800661 · Cited by 158 · see citing works
Tan, K. C. B., Shiu, S. W. M., Chow, W. S., Leng, L., Bucala, R., & Betteridge, D. J. (2006) · Diabetologia · doi:10.1007/s00125-006-0394-1 · Cited by 159 · see citing works
Schlueter, C., Hauke, S., Flohr, A. M., Rogalla, P., & Bullerdiek, J. (2003) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/j.bbaexp.2003.08.008 · Cited by 157 · see citing works
Bartling, B. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh333 · Cited by 157 · see citing works
RAGE and Soluble RAGE: Potential Therapeutic Targets for Cardiovascular Diseases
Koyama, H., Yamamoto, H., & Nishizawà, Y. (2007) · Molecular Medicine · doi:10.2119/2007-00087.koyama · Cited by 156 · see citing works
Self-citationDecreased Endogenous Secretory Advanced Glycation End Product Receptor in Type 1 Diabetic Patients
Katakami, N., Matsuhisa, M., Kaneto, H., Matsuoka, T., Sakamoto, K., Nakatani, Y., Ohtoshi, K., Hayaishi-Okano, R., Kosugi, K., Hori, M., et al. (2005) · Diabetes Care · doi:10.2337/diacare.28.11.2716 · Cited by 155 · see citing works
An update on advanced glycation endproducts and atherosclerosis
Turco, S. D., & Basta, G. (2012) · BioFactors · doi:10.1002/biof.1018 · Cited by 154 · see citing works
Soluble Receptor for Advanced Glycation End Products in Patients With Decreased Renal Function
Kalousová, M., Hodková, M., Kazderová, M., Fialová, J., Tesař, V., Sulková, S., & Zima, T. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.12.028 · Cited by 153 · see citing works
RAGE Expression in Tumor-Associated Macrophages Promotes Angiogenesis in Glioma
Chen, X., Zhang, L., Zhang, I. Y., Liang, J., Wang, H., Ouyang, M., Wu, S., da Fonseca, A. C. C., Weng, L., Yamamoto, Y., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1240 · Cited by 153 · see citing works
Self-citationCheng, C., Tsuneyama, K., Kominami, R., Shinohara, H., Sakurai, S., Yonekura, H., Watanabe, T., Takano, Y., Yamamoto, H., & Yamamoto, Y. (2005) · Modern Pathology · doi:10.1038/modpathol.3800450 · Cited by 153 · see citing works
Self-citationMaillard reaction in food allergy: Pros and cons
Gupta, R. K., Gupta, K., Sharma, A., Das, M., Ansari, I. A., & Dwivedi, P. D. (2016) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2016.1152949 · Cited by 150 · see citing works
Yamagishi, S.-I., Adachi, H., Nakamura, K., Matsui, T., Jinnouchi, Y., Takenaka, K., Takeuchi, M., Enomoto, M., Furuki, K., Hino, A., et al. (2006) · Metabolism · doi:10.1016/j.metabol.2006.05.007 · Cited by 148 · see citing works
Self-citationRoles of the Receptor for Advanced Glycation Endproducts in Diabetes-Induced Vascular Injury
Yonekura, H., Yamamoto, Y., Sakurai, S., Watanabe, T., & Yamamoto, H. (2005) · Journal of Pharmacological Sciences · doi:10.1254/jphs.cpj04005x · Cited by 147 · see citing works
Self-citationRAGE signaling regulates the progression of diabetic complications
Taguchi, K., & Fukami, K. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1128872 · Cited by 144 · see citing works
Nakamura, K., Yamagishi, S., Adachi, H., Kurita‐Nakamura, Y., Matsui, T., Yoshida, T., Sato, A., & Imaizumi, T. (2006) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.690 · Cited by 143 · see citing works
Park, I. H. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2003.11.027 · Cited by 140 · see citing works
Yan, X. X., Lu, L., Peng, W. H., Wang, L. J., Zhang, Q., Zhang, R., Chen, Q., & Shen, W. F. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.12.016 · Cited by 138 · see citing works
RAGE: A Multi-Ligand Receptor Unveiling Novel Insights in Health and Disease
Alexiou, P., Chatzopoulou, M., Pegklidou, K., & Demopoulos, V. J. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710791331086 · Cited by 138 · see citing works
Role of Soluble Receptor for Advanced Glycation End Products on Endotoxin-induced Lung Injury
Zhang, H., Tasaka, S., Shiraishi, Y., Fukunaga, K., Yamada, W., Seki, H., Ogawa, Y., Miyamoto, K., Nakano, Y., Hasegawa, N., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200707-1069oc · Cited by 135 · see citing works
Prasad, C., Davis, K. E., Imrhan, V., Juma, S., & Vijayagopal, P. (2017) · American Journal of Lifestyle Medicine · doi:10.1177/1559827617708991 · Cited by 134 · see citing works
Nakamura, K., Yamagishi, S., Adachi, H., Kurita‐Nakamura, Y., Matsui, T., Yoshida, T., & Imaizumi, T. (2007) · Molecular Medicine · doi:10.2119/2006-00090.nakamura · Cited by 134 · see citing works
Toxic Advanced Glycation End Products (TAGE) Theory in Alzheimer’s Disease
Sato, T., Shimogaito, N., Wu, X., Kikuchi, S., Yamagishi, S., & Takeuchi, M. (2006) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317506289277 · Cited by 133 · see citing works
Self-citationReceptor for advanced glycation end products and age-related macular degeneration
Howes, K. A., Liu, Y., Dunaief, J. L., Milam, A., Frederick, J. M., Marks, A., & Baehr, W. (2004) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-0404 · Cited by 131 · see citing works
Erusalimsky, J. D. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101958 · Cited by 131 · see citing works
sRAGE is Elevated in Septic Patients and Associated With Patients Outcome
Bopp, C., Hofer, S., Weitz, J., Bierhaus, A., Nawroth, P. P., Martin, E., Büchler, M. W., & Weigand, M. A. (2007) · Journal of Surgical Research · doi:10.1016/j.jss.2007.07.014 · Cited by 131 · see citing works
Danger Signals in the Initiation of the Inflammatory Response after Myocardial Infarction
de Haan, J. J., Smeets, M. B., Pasterkamp, G., & Arslan, F. (2013) · Mediators of Inflammation · doi:10.1155/2013/206039 · Cited by 127 · see citing works
Implications and Future Perspectives of AGEs in PCOS Pathophysiology
Merhi, Z. O., Kandaraki, E., & Diamanti‐Kandarakis, E. (2019) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2019.01.005 · Cited by 124 · see citing works
Decreased plasma soluble RAGE in patients with hypercholesterolemia: Effects of statins
Santilli, F., Bucciarelli, L. G., Noto, D., Cefalu, A. B., Davì, V., Ferrante, E., Pettinella, C., Averna, M. R., Ciabattoni, G., & Davı̀, G. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.06.017 · Cited by 124 · see citing works
Receptor for Advanced Glycation End Products Is Involved in Impaired Angiogenic Response in Diabetes
Shoji, T., Koyama, H., Morioka, T., Tanaka, S., Kizu, A., Motoyama, K., Mori, K., Fukumoto, S., Shioi, A., Shimogaito, N., et al. (2006) · Diabetes · doi:10.2337/db05-1375 · Cited by 124 · see citing works
Self-citationTakeuchi, M., & Yamagishi, S. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-0974 · Cited by 122 · see citing works
Self-citationHyperoxia sensing: From molecular mechanisms to significance in disease
Gore, A., Muralidhar, M., Espey, M. G., Degenhardt, K., & Mantell, L. L. (2010) · Journal of Immunotoxicology · doi:10.3109/1547691x.2010.492254 · Cited by 120 · see citing works
Nin, J. W. M., Jorsal, A., Ferreira, I., Schalkwijk, C. G., Prins, M. H., Parving, H., Tarnow, L., Rossing, P. R., & Stehouwer, C. D. A. (2010) · Diabetes · doi:10.2337/db09-1509 · Cited by 121 · see citing works
- Authors
- YONEKURA, H., YAMAMOTO, Y., SAKURAI, S., PETROVA, R. G., ABEDIN, M. J., LI, H., YASUI, K., TAKEUCHI, M., MAKITA, Z., TAKASAWA, S., OKAMOTO, H., WATANABE, T., & YAMAMOTO, H.
- Affiliations
- Kanazawa University (JP)
- Hokuriku University (JP)
- Kurume University (JP)
- Tohoku University (JP)
- Corresponding author
- YONEKURA, Hideto
- YAMAMOTO, Yasuhiko
- SAKURAI, Shigeru
- LI, Hui
- YASUI, Kiyoshi
- WATANABE, Takuo
- YAMAMOTO, Hiroshi
- ORCID
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 2003-03-15
- Volume
- 370
- Issue
- 3
- Pages
- 1097-1109
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- PMC
- PMC1223244
- OpenAlex
- W2021346724
- Cited by
- 716
- References
- 46
- Citations by year
- 2026: 12 · 2025: 8 · 2024: 15 · 2023: 34 · 2022: 32 · 2021: 34 · 2020: 26 · 2019: 27 · 2018: 24 · 2017: 26 · 2016: 42 · 2015: 34 · 2014: 20 · 2013: 38 · 2012: 41
- FWCI
- 15.79
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- public-domain
- Locations
- Biochemical Journal (publishedVersion, public-domain)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Education, Culture, Sports, Science and Technology (13670113)
- Japan Society for the Promotion of Science (97L00805, 13470197, 13670113)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Connective Tissue Growth Factor Research
- Keywords
- receptor for advanced glycation end products, advanced glycation end products, vascular endothelial cells, pericytes, diabetic vascular complications, vascular endothelial growth factor, cell proliferation
- MeSH terms
- Receptor for Advanced Glycation End Products, Amino Acid Sequence, Animals, Cell Movement, Cells, Cultured, Diabetes Mellitus, Endothelium, Vascular, Humans, Lymphokines, Molecular Sequence Data, Oligosaccharides, Protein Binding, Receptors, Immunologic, Endothelial Growth Factors, Sequence Alignment, Glycation End Products, Advanced, Alternative Splicing, Protein Isoforms, Pericytes, Mitogen-Activated Protein Kinases, Intercellular Signaling Peptides and Proteins, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
